Export 607 results:
M. Morgan, G. (2002).  Risk communication: A mental models approach.
Alary, M., & (1991).  Risk factors for contamination of domestic hot water systems by legionellae.. Applied and Environmental Microbiology. 57, 2360–2367.
Nam, S.. U. K. U., , , , , , et al. (2011).  Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia. Scandinavian Journal of Infectious Diseases. 43, 792.
Friedman, CR. (2004).  Risk factors for sporadic Campylobacter infection in the United States: a case -control study in FoodNet sites.
Fischhoff, B.. (1995).  Risk perception and communication unplugged: twenty years of process. Risk analysis: an official publication of the Society for Risk Analysis. 15, 2.
Westerman, E.. L. (1982).  Rocky Mountain spotless fever: A dilemma for the clinician. Arch. Intern. Med. 142, 1106-1107.
(Submitted).  Rocky Mountain Spotted Fever.
Kaplowitz, L.. G., Fischer J.. J., & Sparling P.. F. (1981).  Rocky Mountain spotted fever: a clinical dilemma. Curr. Clin. Top. Infect. Dis. 2, 89-108.
DuPont, HL., Hornick RB., Dawkins AT., Heiner GG., Fabrikant IB., Jr CL. Wisseman, et al. (1973).  Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. Journal of Infectious Diseases. 128, 340–344.
Walker, D.. (1989).  Rocky Mountain spotted fever: a disease in need of microbiological concern. Clinical microbiology reviews. 2, 227-240.
Helmick, C. G., Bernard K. W., & D'Angelo L. J. (1984).  Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. Journal of Infectious Diseases. 150, 480-488.
Helmick, C.. G., Bernard K.. W., & D'Angelo L.. J. (1984).  Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. Dis. J. Infect. 150, 480-488.
Haynes, R.. E., Sanders D.. Y., & Cramblett H.. G. (1970).  Rocky Mountain spotted fever: Comments on recognition and management based on a study of patients. Clin. Pediatr. 17, 685-693.
Hattwick, M.. A., O’Brien R.. J., & Hanson B.. F. (1976).  Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Intern Med. 84, 6.
Middleton, D.. B. (1978).  Rocky Mountain spotted fever: gastrointestinal and laboratory manifestations. South. Med J. 71, 629-632.
Del Fiol, F. de S. á, & (2010).  Rocky Mountain spotted fever in Brazil. Revista Panamericana de Salud Pública. 27, 461-466.
Benson, M.., & Walker D.. H. (1984).  Rocky Mountain spotted fever in the differential diagnosis of the acute abdomen. Contemp. Surg.. 24, 79-83.
Chapman, A. S., & (2006).  Rocky Mountain spotted fever in the United States, 1997–2002. Vector-Borne & Zoonotic Diseases. 6, 170-178.
Walker, D.. H., Lesesne H.. R., Varma V.. A., & Thacker W.. C. (1985).  Rocky Mountain spotted fever mimicking acute cholecystitis. 2194-2196.
Walker, D.. H., Henderson F.. W., & Hutchins G.. M. (1986).  Rocky Mountain spotted fever: mimicry of appendicitis or acute surgical abdomen?. Am. J. Dis. Child. 140, 742-744.
Tacket, C.. O., Sztein M.. B., Losonsky G.., Abe A.., Finlay B.. B., McNamara B.. P., et al. (2000).  Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68, 6.
Donnenberg, M.. S., Tacket C.. O., James S.. P., Losonsky G.., Nataro J.. P., Wasserman S.. S., et al. (1993).  Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. Journal of Clinical Investigation. 92, 3.
de Magny, GC., & Mozumder PK. (2011).   Role of zooplankton diversity in Vibrio cholerae population dynamics and in the incidence of cholera in the Bangladesh Sundarbans.